Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 3.


Sadiq, Soban, Owen, Euan, Foster, Terry, Knight, Katy, Wang, Lihui, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Clark, Richard ORCID: 0000-0002-1261-3299 and Pushpakom, Sudeep ORCID: 0000-0002-6682-4235
(2019) Nilotinib-induced metabolic dysfunction: insights from a translational study using in vitro adipocyte models and patient cohorts. Leukemia, 33. 1810 - 1814.


Pushpakom, SP ORCID: 0000-0002-6682-4235, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Taylor, Claire, Foster, Terry, Spowart, Cath, Garcia-Finana, M, Kemp, GJ ORCID: 0000-0002-8324-9666, Jaki, Thomas, Khoo, SH, Williamson, Paula ORCID: 0000-0001-9802-6636
et al (show 1 more authors) (2019) TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy. Clinical Infectious Diseases.


Pushpakom, Sudeep, Kolamunnage-Dona, Ruwanthi, Taylor, Claire ORCID: 0000-0003-4746-9730, Foster, Terry ORCID: 0000-0001-7725-7902, Spowart, Catherine ORCID: 0000-0001-8641-2871, Garcia-Finana, Marta ORCID: 0000-0003-4939-0575, Kemp, Graham J, Jaki, Thomas ORCID: 0000-0002-1096-188X, Khoo, Saye ORCID: 0000-0002-2769-0967, Williamson, Paula
et al (show 1 more authors) (2019) Telmisartan to reduce insulin resistance in HIV-positive individuals on combination antiretroviral therapy: the TAILoR dose-ranging Phase II RCT.

This list was generated on Mon Aug 16 06:31:55 2021 BST.